Next 10 |
home / stock / glaxf / glaxf news
2024-05-28 03:05:58 ET Summary On May 1, London-based GSK published financial results for the first three months of 2024, which pleasantly surprised me. Sales of Jemperli for the first three months of 2024 amounted to about $101 million, up 46.6% from the previous quarter. The...
2024-05-27 01:45:30 ET Summary Gilead is sitting at one of the lowest valuations in the Big Pharma sector, with a high and sustainable 4.6% dividend yield available for new buyers. The stock has an enviable track record of rising strongly in price when turmoil hits Wall Street and...
2024-05-23 16:47:14 ET Summary CureVac N.V. is developing an avian influenza [H5N1] vaccine with GSK plc; A phase 1 study is already underway to evaluate this vaccine. It is working on a seasonal influenza vaccine, but further optimization is needed to target influenza B; Dose-opt...
2024-05-22 11:19:16 ET Summary GSK plc has advanced asthma care with their innovative depemokimab therapy, which is an IL-5 inhibitor and offers a long-acting option for severe asthma. Depemokimab demonstrated a significant reduction in asthma exacerbations over 52 weeks in clinic...
2024-05-08 12:01:57 ET Summary Our 3-step process focuses on wide-moat stocks (as per Morningstar’s rating). We are only interested in those targets that are attractively valued in historical comparison. We share the heat map of the most investible candidates that may b...
2024-05-04 00:00:06 ET GSK plc (GSK) Q1 2024 Earnings Conference Call May 01, 2024 03:00 AM ET Company Participants Nick Stone - Head of Investor Relations Emma Walmsley - Chief Executive Officer Luke Miels - Chief Commercial Officer Deborah Waterhouse - Chie...
2024-04-25 17:49:16 ET Summary The Annual Meeting of the American Society of Clinical Oncology is a major event for clinicians and researchers in the field of oncology. The plenary session will feature presentations on topics such as esophageal cancer, melanoma, and lung cancer. ...
2024-04-23 11:37:17 ET Summary Spero Therapeutics, Inc. has continued to build and advance its pipeline over the past several months and is now on the verge of generating landmark data with multi-bagger potential. Spero has excellent downside protection and additional upside from ...
2024-04-19 04:02:55 ET Summary GSK trades at lower price multiples compared to competitors due to weaker pipeline. GSK's revenue growth in 2023 was modest, but it has strong performers in its product mix. GSK needs to demonstrate the effectiveness and efficiency of its pipelin...
2024-04-17 01:50:40 ET Summary Our 3-step process focuses on wide-moat stocks (as per Morningstar’s rating). We are only interested in those targets that are attractively valued in historical comparison. We share the heat map of the most investable candidates that may b...
News, Short Squeeze, Breakout and More Instantly...
GlaxoSmithKline Plc Company Name:
GLAXF Stock Symbol:
OTCMKTS Market:
New York City, NY:March 27, 2020 – Published via (Wired Release) – Recent Research and Future Market Potential of Color Ultrasonic Diagnostic Apparatus Market in Global Industry: 2020 Research and New Innovations in Medical Devices Sector. The prime objective of the report is to ...
New York City, NY:March 27, 2020 – Published via (Wired Release) – Recent Research and Future Market Potential of Chemical Mechanical Planarization Slurries Market in Global Industry: 2020 Research and New Innovations in Chemicals and Materials Sector. The prime objective of the ...
New York City, NY:March 27, 2020 – Published via (Wired Release) – Recent Research and Future Market Potential of Consumer Healthcare Market in Global Industry: 2020 Research and New Innovations in Medical Devices Sector. The prime objective of the report is to offer updates and ...